Turkish Guideline for Atopic Dermatitis 2018

J Turk Acad Dermatol 2018;12(2):0-0

1. İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, İstanbul,

2. Uludağ Üniversitesi Tıp Fakültesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Bursa,

3. Erciyes Üniversitesi Tıp Fakültesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Bursa,

4. Sağlık Bilimleri Üniversitesi, Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Ankara,

5. Ankara Yıldırım Beyazıt Üniversitesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Ankara,

6. Karadeniz Teknik Üniversitesi Tıp Fakültesi, Deri ve Zührevi Hastalıkları Anabilim Dalı, Trabzon, Türkiye

No information available.

No information available

PDF

Cite

Request

ABSTRACT

Background:

Atopic dermatitis (AD) is a common inflammatory skin disease worldwide and life-long prevalence thereof can exceed 20% in developed countries. The prevalence of the disease increases gradually in developing countries and in African and Asian countries with low income.

AD affects quality of life unfavorably in a significant manner. The cost of AD is quite high both due to healthcare expenses required for treatment and causing labor loss. Patients receive long-term treatments owing to the fact that it is a disease with a chronic course and there is no curative treatment which also cause medicine expenses and a number of toxicities.

This guideline covers etiology, clinic diagnosis, laboratory, complications and treatment approaches for atopic dermatitis in details.